| Overview |
| bsm-90086r-50µL |
| Bcl10 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Bcl10 |
| 170-233/233 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 8915 |
| O95999 |
| BCL10; BCL10 Immune Signaling Adaptor; CIPER; C-E10; ME10; CLAP; CARMEN; CED-3/ICH-1 Prodomain Homologous E10-Like Regulator; Mammalian CARD-Containing Adapter Molecule E10; CARD-Containing Molecule Enhancing NF-Kappa-B; Caspase-Recruiting Domain-Containing Protein; CARD-Containing Apoptotic Signaling Protein; CARD Containing Molecule Enhancing NF-KB; CARD-Containing Proapoptotic Protein; CARD-Like Apoptotic Protein; B-Cell Lymphoma/Leukemia 10; Cellular Homolog Of VCARMEN; B Cell CLL/Lymphoma 10; Cellular-E10; CCARMEN; HCLAP; BCL10 Immune Signaling Adaptor; B-Cell; CLL/Lymphoma 10; Bcl-10; IMD37 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |